QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.97
+2.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 534.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.22x
- PEG TTM
- —
- Price / book
- 2.52x
- Price / sales
- 4.97x
- Price / cash flow
- -13.47x
Enterprise value
- Enterprise value
- $166.1M
- EV / sales
- 3.09x
- EV / EBITDA
- 4.81x
- EV / EBIT
- 7.74x
- Market cap
- $267.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026